Membrane Processes in Biotechnology and Pharmaceutics
- Catherine Charcosset, 1. Ingenieur in Mechanics at "Ecole Centrale de Lyon" (ECL, Lyon, France) 1984-1987 2. Master in Mechanics of Solids at ECL (Prof. F. Sidoroff) 1986-1987 3. PhD Thesis " Plasma fractionation by membrane filtration » at the University of Technology of Compiègne (Prof. M. Y. Jaffrin, Compiègne, France) 1987-1990 4. Postdoctoral fellow at Dpt of Chemical Engineering, Massachussetts Institute of Technology, MIT, Cambridge, USA (Prof. C. K. Colton) 1990-1992 "Affinity membranes for the purification of immunoglobulins" 5. Research scientist at CNRS in GEMICO (Centre de Génie Chimique des Milieux Complexes, Nancy, France) 1992-1994 6. Research scientist at CNRS in LAGEP (Laboratoire d'Automatique et de Génie des Procédés, UMR 5007 CNRS, Villeurbanne, France) 1994 , Centre National de la Recherche Scientifique (CNRS), Universite de Lyon, France
Membrane processes are increasingly used in pharmaceutical and biochemical engineering and biotechnology for concentration and purification, synthesis of molecules and drug delivery systems, and support for biochemical reactions. This book provides a state-of-the art overview of the classical membrane processes used in pharmaceutical and biochemical engineering and biotechnology, such as ultrafiltration, microfiltration, virus filtration, membrane chromatography, membrane emulsification, liquid membranes and membrane bioreactors. It describes the general rules (principles, choice of configurations, membranes, parameters, etc.), recent developments (fouling control, increase permeate flux and selectivity, etc.), applications, and theoretical descriptions. Further, it presents emerging processes such as solvent resistant nanofiltration and membrane crystallization.
Scientists having an interest in membrane processes in pharmaceutical, biotechnological, and chemical engineering. PhD students pharmaceutical, biotechnological, and chemical engineering. Scientific libraries. Secondary Market:
Membrane companies, pharmaceutical and biotechnological industries.